ES8104243A1 - Un procedimiento para la preparacion de derivados de imida- zolidina - Google Patents

Un procedimiento para la preparacion de derivados de imida- zolidina

Info

Publication number
ES8104243A1
ES8104243A1 ES490799A ES490799A ES8104243A1 ES 8104243 A1 ES8104243 A1 ES 8104243A1 ES 490799 A ES490799 A ES 490799A ES 490799 A ES490799 A ES 490799A ES 8104243 A1 ES8104243 A1 ES 8104243A1
Authority
ES
Spain
Prior art keywords
compound
formula
imidazole derivatives
preparing imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490799A
Other languages
English (en)
Spanish (es)
Other versions
ES490799A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES490799A0 publication Critical patent/ES490799A0/es
Publication of ES8104243A1 publication Critical patent/ES8104243A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES490799A 1979-04-24 1980-04-23 Un procedimiento para la preparacion de derivados de imida- zolidina Expired ES8104243A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH383779 1979-04-24

Publications (2)

Publication Number Publication Date
ES490799A0 ES490799A0 (es) 1981-04-16
ES8104243A1 true ES8104243A1 (es) 1981-04-16

Family

ID=4264536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490799A Expired ES8104243A1 (es) 1979-04-24 1980-04-23 Un procedimiento para la preparacion de derivados de imida- zolidina

Country Status (13)

Country Link
EP (1) EP0017976B1 (enExample)
JP (1) JPS55143974A (enExample)
KR (1) KR850000719B1 (enExample)
AT (1) ATE3860T1 (enExample)
CA (1) CA1135706A (enExample)
DE (1) DE3063837D1 (enExample)
DK (1) DK174480A (enExample)
ES (1) ES8104243A1 (enExample)
FI (1) FI801184A7 (enExample)
GR (1) GR67605B (enExample)
HU (1) HU184271B (enExample)
NO (1) NO801182L (enExample)
PT (1) PT71135B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2724169B1 (fr) * 1994-09-06 1997-01-03 Roussel Uclaf Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
TW521073B (en) * 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
FR2715402B1 (fr) * 1994-01-05 1996-10-04 Roussel Uclaf Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
EP1709193B1 (en) 2003-12-19 2011-03-16 The Regents of The University of California Methods and materials for assessing prostate cancer therapies
WO2005099693A2 (en) 2004-02-24 2005-10-27 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
ES2689292T3 (es) 2006-03-27 2018-11-13 The Regents Of The University Of California Modulador del receptor de andrógenos para el tratamiento del cáncer de próstata y enfermedades asociadas con el receptor de andrógenos
NZ572374A (en) 2006-03-29 2011-12-22 Univ California Diarylthiohydantoin compounds
EP2220050A2 (en) 2007-10-26 2010-08-25 The Regents Of The University Of California Diarylhydantoin compounds as androgen receptor modulators
SG10201907588XA (en) 2010-02-16 2019-09-27 Aragon Pharmaceuticals Inc Androgen Receptor Modulators And Uses Thereof
CN115737643A (zh) 2012-09-26 2023-03-07 阿拉贡药品公司 用于治疗非转移性去势抵抗性前列腺癌的抗雄激素
DK2945628T3 (da) 2013-01-15 2020-05-04 Aragon Pharmaceuticals Inc Androgen receptormodulator i kombination med abirateronacetat og prednison til behandling af prostatacancer
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
MX2020003845A (es) 2017-10-16 2020-11-06 Aragon Pharmaceuticals Inc Antiandrógenos para el tratamiento de cáncer de próstata no metastásico resistente a la castración.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997037A (en) * 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
US3340070A (en) * 1963-08-23 1967-09-05 Shell Oil Co Artificial sweetening agent
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
IL55774A (en) * 1977-10-28 1982-04-30 Sparamedica Ag Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture

Also Published As

Publication number Publication date
HU184271B (en) 1984-07-30
FI801184A7 (fi) 1981-01-01
EP0017976A2 (de) 1980-10-29
ES490799A0 (es) 1981-04-16
GR67605B (enExample) 1981-08-31
EP0017976A3 (en) 1981-04-01
NO801182L (no) 1980-10-27
KR850000719B1 (ko) 1985-05-23
PT71135B (en) 1981-08-07
PT71135A (en) 1980-05-01
DE3063837D1 (en) 1983-07-28
JPS55143974A (en) 1980-11-10
ATE3860T1 (de) 1983-07-15
EP0017976B1 (de) 1983-06-22
DK174480A (da) 1980-10-25
KR830002722A (ko) 1983-05-30
CA1135706A (en) 1982-11-16

Similar Documents

Publication Publication Date Title
ES8203076A1 (es) Procedimiento para preparar derivados de guanidina.
EP0017976A3 (en) Process for preparing imidazole derivatives and the starting materials used in this process
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
ES428295A1 (es) Procedimiento para la obtencion de derivados de canfeno sulfonados.
JPS57175188A (en) 2-aryl-2,1-h-azoyl(alkyl)-gamma-butyllactones
GB1489803A (en) Aminoacetamides and a process for their preparation
GB1029228A (en) A method of preparing new quaternary ammonium salts with disinfectant activity
KR840000530A (ko) 신규 벤조트리아졸의 제조방법
HUT37116A (en) Process for production of phenil-alanin derivatives
ES317157A1 (es) Un metodo de preparar un compuesto derivado de los acidos fenoxiacetico y feniltioacetico.
RO87039B1 (ro) Procedeu pentru prepararea unor derivati de acid penicilanic
BR8603787A (pt) Compostos heterociclicos,e,processo de sua preparacao e aplicacao
ES8304920A1 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
GB1422216A (en) Phenyl-formamidine derivatives
GB1505020A (en) Substituted 2-phenylimino-thiazolines a process for their preparation and their use as ectoparasiticides
HUT53586A (en) Process for producing glutaric acid derivatives
ES8300733A1 (es) Un procedimiento para la preparacion de ranitidina.
ES464547A1 (es) Un procedimiento para la preparacion imidazolidin.2,4-dionas
MY105374A (en) A process for the preparation of 7-amino-3-methoxymeth- yl-ceph-3-em-4-carboxylic acid.
GB1085083A (en) Improvements in or relating to benzimidazoles and the manufacture thereof
SE7507318L (sv) Forfarande for framstellning av aromatiska uretaner.
GB1423017A (en) Phosphorothionoamidate derivatives having plant growth regulating properties
CA1274248C (en) METHOD FOR THE PREPARATION OF .alpha.-ARYLACANO ESTERS
ES430903A1 (es) Un procedimiento para la preparacion del acido (1-oxo-2-fe- nil, halofenil o tienil-2-metil-6, 7-dicloro-5-indaniloxi) acetico.
GB1301996A (enExample)